AcuCort outlines international expansion plans at Stockholm capital markets day

• AcuCort hosted a Capital Markets Day in Stockholm on Oct. 13, outlining its strategy for expansion in Europe and the US.
• Management highlighted a commercial agreement with Glenmark Pharmaceuticals covering six European markets, targeting launches in 2027.
• Preparations continue for a US New Drug Application filing for Zeqmelit.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AcuCort AB published the original content used to generate this news brief via Cision (Ref. ID: 202610140230BITN____UKPR__EN_20261013-BIT-3031-0) on October 14, 2026, and is solely responsible for the information contained therein.